<DOC>
	<DOCNO>NCT02423759</DOCNO>
	<brief_summary>The aim study evaluate whether change antibiotic prophylaxis fluoroquinolones alone fluoroquinolones plus gentamicin 160mg single IM dose target antibiotic prophylaxis accord rectal swab culture would influence infectious complication rate men undergo transrectal ultrasound-guided prostate biopsy .</brief_summary>
	<brief_title>A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy</brief_title>
	<detailed_description>Introduction Transrectal ultrasound ( TRUS ) guide prostate biopsy standard procedure histological diagnosis grade prostate cancer consequently help provide appropriate line treatment . Risks infectious complication post TRUS-guided biopsy increase last year . In study , total 5798 TRUS-guided biopsy perform 2002 2011 . Increased incidence infectious complication note 0.52 infection per 100 biopsy 2002 2009 2.15 infection per 100 biopsy 2010 2011 ( P &lt; 0.001 ) . The common organism find responsible infectious complication Escherichia coli ( E. Coli ) . The American Urological Association best practice policy statement recommend antibiotic prophylaxis prior transrectal prostate biopsy . The current practice give patient dose oral fluoroquinolone ( FQ ) 30 60 minute biopsy continue 2 3 day . Recent study show 2 % patient develop febrile urinary tract infection even urosepsis require hospitalization intravenous antibiotic . There considerable concern regard rise incidence community-acquired antibiotic-resistant organism . It propose resistant organism introduce bladder blood stream rectum procedure 's patient already colonize resistant organism may high risk . Thereby , author suggest target rectal swab culture ( TRUS ) -guided biopsy give appropriate antibiotic prophylaxis aim reduce post biopsy infection rate minimize unnecessary broad-spectrum antibiotic use . Retrospective data show septicemia see 24 300 ( 8 % ) 15 897 ( 1.7 % ) patient receive peri-procedure ciprofloxacin alone patient receive ciprofloxacin plus single IV dose amikacin injection respectively ( p=0.001 ) . E. Coli resistant quinolones responsible 33 39 ( 84.6 % ) septicemic case . In retrospective study UK , 12.9 % develop infectious complication follow prostate biopsy patient receive co-amoxiclav gentamycin . In another retrospective study , hospitalization rate due post-biopsy infection 3.8 % compare 0.6 % ( p=0.001 ) patient receive standard ciprofloxacin augment prophylaxis ciprofloxacin plus single IM 80mg gentamycin respectively . Of admitted patient receive standard prophylaxis , 73 % fluoroquinolone resistant E. Coli urinary infection and/or bacteremia 9 % strain resistant gentamicin . Multivariate analysis show standard regimen significantly associate hospital admission due post-biopsy infection . The augmented regimen result cost saving $ 15,700 per 100 patient compare standard regimen . Diabetes find 4 % fluoroquinolone sensitive group vs 14.7 % resistant group ( p &lt; 0.001 ) . Biopsy history associate resistance . Urosepsis systemic reaction body bacterial infection urogenital organ risk life-threatening event include shock . Systemic inflammatory response syndrome ( SIRS ) criterion define 2 follow variable ; increase body temperature 38°C , heart rate 90 beat per minute , respiratory rate 20 per minute arterial carbon dioxide tension ( PaCO2 ) less 32mm Hg abnormal white blood cell count ( &gt; 12,000/µL &lt; 4,000/µL ) Aim work ; The aim study evaluate whether change antibiotic prophylaxis fluoroquinolones alone fluoroquinolones plus gentamicin 160mg single IM dose target antibiotic prophylaxis accord rectal swab culture would influence infectious complication rate men undergo transrectal ultrasound-guided prostate biopsy .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>1 . Prothrombin concentration &gt; 70 % 2 . Platelet count &gt; 100.000/cm 1 . Acute prostatitis ( positive symptom sign ) 2 . Patients compromise renal function ( serum creatinine &gt; 1.6 mg/dl ) 3 . Uncontrolled DM 4 . Patients immunosuppressive therapy 5 . Active steroid intake 6 . Untreated bleeding diathesis</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Chemoprevention</keyword>
</DOC>